Search Results - "Dale, Glenn"

Refine Results
  1. 1

    The Role of Neutrophil Elastase Inhibitors in Lung Diseases by Polverino, Eva, Rosales-Mayor, Edmundo, Dale, Glenn E., Dembowsky, Klaus, Torres, Antoni

    Published in Chest (01-08-2017)
    “…In many respiratory diseases characterized by an intense inflammatory response, the balance between proteolytic enzymes (proteases, including elastases) and…”
    Get full text
    Journal Article
  2. 2

    Murepavadin: a new antibiotic class in the pipeline by Martin-Loeches, Ignacio, Dale, Glenn E, Torres, Antoni

    Published in Expert review of anti-infective therapy (03-04-2018)
    “…With the increase in multi-drug resistant P. aeruginosa, antimicrobials with a novel mechanism of action are needed that can target these infections. Areas…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Pharmacokinetics and Safety of Intravenous Murepavadin Infusion in Healthy Adult Subjects Administered Single and Multiple Ascending Doses by Wach, Achim, Dembowsky, Klaus, Dale, Glenn E

    Published in Antimicrobial agents and chemotherapy (01-04-2018)
    “…Murepavadin is the first in class of the outer membrane protein-targeting antibiotics (OMPTA) and a pathogen-specific peptidomimetic antibacterial with a…”
    Get full text
    Journal Article
  5. 5

    Protein epitope mimetic macrocycles as biopharmaceuticals by Luther, Anatol, Moehle, Kerstin, Chevalier, Eric, Dale, Glenn, Obrecht, Daniel

    Published in Current opinion in chemical biology (01-06-2017)
    “…[Display omitted] •Medium-sized macrocycles can address novel disease-relevant targets.•Protein epitope mimetics (PEM) are mimics β-hairpin and α-helical…”
    Get full text
    Journal Article
  6. 6

    Antimicrobial Activity of Murepavadin Tested against Clinical Isolates of Pseudomonas aeruginosa from the United States, Europe, and China by Sader, Helio S, Dale, Glenn E, Rhomberg, Paul R, Flamm, Robert K

    Published in Antimicrobial agents and chemotherapy (01-07-2018)
    “…Murepavadin (formerly POL7080), a 14-amino-acid cyclic peptide, and comparators were tested by the broth microdilution method against 1,219 isolates from 112…”
    Get full text
    Journal Article
  7. 7

    Rifabutin for infusion (BV100) for the treatment of severe carbapenem-resistant Acinetobacter baumannii infections by Trebosc, Vincent, Kemmer, Christian, Lociuro, Sergio, Gitzinger, Marc, Dale, Glenn E.

    Published in Drug discovery today (01-09-2021)
    “…•A unexpected activity of rifabutin (RBT) towards A. baumanni has been discovered.•RBT displays a potent activity towards A. baumannii in iron depleted…”
    Get full text
    Journal Article
  8. 8

    Pharmacokinetics, Tolerability, and Safety of Murepavadin, a Novel Antipseudomonal Antibiotic, in Subjects with Mild, Moderate, or Severe Renal Function Impairment by Dale, Glenn E, Halabi, Atef, Petersen-Sylla, Marc, Wach, Achim, Zwingelstein, Christian

    Published in Antimicrobial agents and chemotherapy (01-09-2018)
    “…This open-label, nonrandomized, single-dose, phase 1 study evaluated the pharmacokinetics and safety of murepavadin, a novel peptide antibiotic for the…”
    Get full text
    Journal Article
  9. 9

    Murepavadin activity tested against contemporary (2016-17) clinical isolates of XDR Pseudomonas aeruginosa by Sader, Helio S, Flamm, Robert K, Dale, Glenn E, Rhomberg, Paul R, Castanheira, Mariana

    Published in Journal of antimicrobial chemotherapy (01-09-2018)
    “…Murepavadin (POL7080) represents the first member of a novel class of outer membrane protein-targeting antibiotics. Murepavadin acts by binding to LPS…”
    Get full text
    Journal Article
  10. 10

    Design and synthesis of water-soluble prodrugs of rifabutin for intraveneous administration by Antraygues, Kevin, Maingot, Mathieu, Schellhorn, Birgit, Trebosc, Vincent, Gitzinger, Marc, Deprez, Benoit, Defert, Olivier, Dale, Glenn E., Bourotte, Marilyne, Lociuro, Sergio, Willand, Nicolas

    Published in European journal of medicinal chemistry (05-08-2022)
    “…Acinetobacter baumannii is a gram-negative bacterium causing severe hospital-acquired infections such as bloodstream infections or pneumonia. Moreover,…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Susceptibility of Pseudomonas aeruginosa Recovered from Cystic Fibrosis Patients to Murepavadin and 13 Comparator Antibiotics by Ekkelenkamp, Miquel B, Cantón, Rafael, Díez-Aguilar, María, Tunney, Michael M, Gilpin, Deirdre F, Bernardini, Francesca, Dale, Glenn E, Elborn, J Stuart, Bayjanov, Jumamurat R, Fluit, Ad

    Published in Antimicrobial agents and chemotherapy (27-01-2020)
    “…The objective was to determine the antimicrobial susceptibility of isolates cultured from cystic fibrosis (CF) patients and explore associations between strain…”
    Get full text
    Journal Article
  14. 14

    Antimicrobial activity of POL7306 tested against clinical isolates of Gram-negative bacteria collected worldwide by Sader, Helio S, Rhomberg, Paul R, Duncan, Leonard R, Locher, Hans H, Dale, Glenn E, Flamm, Robert K

    Published in Journal of antimicrobial chemotherapy (01-06-2020)
    “…POL7306 belongs to a new class of peptidomimetic outer-membrane-protein-targeting antibiotics with a novel mechanism of action. POL7306 is in development for…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Structure of human Endothelin-converting Enzyme I Complexed with Phosphoramidon by Schulz, Henk, Dale, Glenn E., Karimi-Nejad, Yasmin, Oefner, Christian

    Published in Journal of molecular biology (09-01-2009)
    “…Endothelin-converting enzyme I (ECE-1) is a mammalian type II integral membrane zinc-containing endopeptidase. ECE-1 catalyzes the final step in the…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Mapping the active site of Escherichia coli malonyl-CoA-acyl carrier protein transacylase (FabD) by protein crystallography by Oefner, Christian, Schulz, Henk, D'Arcy, Allan, Dale, Glenn E.

    “…Malonyl‐CoA–acyl carrier protein transacylase (FabD; EC 2.3.1.39) is a key enzyme in the fatty‐acid biosynthesis pathway of bacteria, catalyzing the transfer…”
    Get full text
    Journal Article
  19. 19

    The protein as a variable in protein crystallization by Dale, Glenn E, Oefner, Christian, D’Arcy, Allan

    Published in Journal of structural biology (01-04-2003)
    “…Strategies for growing protein crystals have for many years been essentially empirical, the protein, once purified to a certain homogeneity, being mixed with a…”
    Get full text
    Journal Article
  20. 20